(CVS) CVS Health - Ratings and Ratios

CVS Health Corporation (NYSE:CVS) is a leading U.S. healthcare provider delivering integrated health solutions through three core segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a wide array of health insurance products, including medical, pharmacy, dental, and behavioral health plans, as well as Medicare Advantage, Medicare Supplement, and Medicaid management services. It serves a diverse client base, including employer groups, individuals, government units, and expatriates. The Health Services segment provides pharmacy benefit management solutions, formulary management, and specialty pharmacy services, catering to employers, insurance companies, and government-sponsored plans. The Pharmacy & Consumer Wellness segment operates a vast network of retail pharmacies, online platforms, and specialty pharmacies, offering prescription drugs, consumer health products, and ancillary services. CVS Health, rebranded from CVS Caremark in 2014, has significantly expanded its healthcare offerings, notably through the acquisition of Aetna in 2018, positioning itself as a major player in the U.S. healthcare ecosystem.

The company, headquartered in Woonsocket, Rhode Island, has a market capitalization of approximately $80.26 billion, with a price-to-earnings ratio of 17.39 and a forward P/E of 10.83, indicating moderate valuation relative to its earnings expectations. Its price-to-book ratio of 1.06 reflects its asset valuation, while the price-to-sales ratio of 0.22 suggests a lower revenue multiple. The return on equity (RoE) of 6.11% highlights its profitability. Technically, CVS stock is trading near its 20-day SMA of $67.60, with a 50-day SMA of $65.40 and a 200-day SMA of $57.90, signaling a recent uptrend. The average trading volume over 20 days is 11.22 million shares, with an average true range (ATR) of 2.28, indicating moderate volatility.